Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


04.02.2019

1 Acta Neurol Scand
1 AJNR Am J Neuroradiol
1 Arch Phys Med Rehabil
1 Brain
1 Curr Treat Options Neurol
1 Int J Neurosci
2 J Neuroimmunol
1 J Neurol Neurosurg Psychiatry
2 Lancet Neurol
1 Rev Neurol
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. RAHN AC, Kopke S, Stellmann JP, Schiffmann I, et al
    Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review.
    Acta Neurol Scand. 2019;139:18-32.
    PubMed     Text format     Abstract available


    AJNR Am J Neuroradiol

  2. FECHNER A, Savatovsky J, El Methni J, Sadik JC, et al
    A 3T Phase-Sensitive Inversion Recovery MRI Sequence Improves Detection of Cervical Spinal Cord Lesions and Shows Active Lesions in Patients with Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2019 Jan 24. pii: ajnr.A5941. doi: 10.3174/ajnr.A5941.
    PubMed     Text format     Abstract available


    Arch Phys Med Rehabil

  3. KRASNIUK S, Classen S, Morrow SA, Tippett M, et al
    Clinical Determinants of Fitness to Drive in Persons with Multiple Sclerosis: Systematic Review.
    Arch Phys Med Rehabil. 2019 Jan 25. pii: S0003-9993(19)30013.
    PubMed     Text format     Abstract available


    Brain

  4. NTRANOS A, Ntranos V, Bonnefil V, Liu J, et al
    Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis.
    Brain. 2019 Jan 28. pii: 5303708. doi: 10.1093.
    PubMed     Text format     Abstract available


    Curr Treat Options Neurol

  5. SAKKAS GK, Giannaki CD, Karatzaferi C, Manconi M, et al
    Sleep Abnormalities in Multiple Sclerosis.
    Curr Treat Options Neurol. 2019;21:4.
    PubMed     Text format     Abstract available


    Int J Neurosci

  6. DOGAN U, Ulas F, Aydin Turkoglu S, Nur Ogun M, et al
    Eyes are Mirror of the Brain: Comparison of Multiple Sclerosis Patients and Healthy Controls Using OCT.
    Int J Neurosci. 2019 Jan 29:1-9. doi: 10.1080/00207454.2019.1576660.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  7. MAUSNER-FAINBERG K, Penn M, Golan M, Benhamou M, et al
    Reduced levels of Coco in sera of multiple sclerosis patients: A potential role in neuro-regeneration failure.
    J Neuroimmunol. 2019 Jan 17. pii: S0165-5728(18)30476.
    PubMed     Text format     Abstract available

  8. DOLATI S, Babaloo Z, Ayromlou H, Ahmadi M, et al
    Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis.
    J Neuroimmunol. 2019 Jan 17. pii: S0165-5728(18)30466.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  9. MANJALY ZM, Harrison NA, Critchley HD, Do CT, et al
    Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2019 Jan 25. pii: jnnp-2018-320050.
    PubMed     Text format     Abstract available


    Lancet Neurol


  10. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet Neurol. 2019 Jan 21. pii: S1474-4422(18)30443.
    PubMed     Text format     Abstract available

  11. STENAGER E
    A global perspective on the burden of multiple sclerosis.
    Lancet Neurol. 2019 Jan 21. pii: S1474-4422(18)30498.
    PubMed     Text format    


    Rev Neurol

  12. PADRON-GONZALEZ AA, Gonzalez-Costa M
    [Glutamate, hypothalamus-hypophysis-adrenal axis and clinical manifestations in multiple sclerosis].
    Rev Neurol. 2019;68:134.
    PubMed     Text format    


    Rev Neurol (Paris)

  13. LEBRUN C, de Seze J
    Demyelinating diseases.
    Rev Neurol (Paris). 2018;174:355.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: